Skip to content
Dx

ICD-10-PCS 2027 procedure code

XW033DAIntroduction of Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension into Peripheral Vein, Percutaneous Approach, New Technology Group 10

✓ Valid for 2027Non-O.R. procedure

Short description: Introduce Donislecel-jujn in Periph Vein, Perc, New Tech 10

Code last changed in FY2025 (effective October 1, 2024). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About XW033DA

XW033DA is the ICD-10-PCS code for a introduction procedure on the peripheral vein using a percutaneous approach with donislecel-jujn allogeneic pancreatic islet cellular suspension (qualifier: new technology group 10). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

With a different device, use XW0333A (maribavir anti-infective), XW0334A (stem cells, somatic), XW0335A (ifezuntirgene inilparvovec), XW0338A (mineral-based topical hemostatic agent), XW0339A (odronextamab antineoplastic), XW033BA (vancomycin-eluting bone void filler) and 4 more.

It is a non-O.R. procedure that is part of the MS-DRG logic for DRG 008 (Simultaneous Pancreas, Islet Cell and Kidney Transplant), DRG 010 (Pancreas or Islet Cell Transplant) and DRG 019 (Simultaneous Pancreas, Islet Cell and Kidney Transplant with Hemodialysis), under the surgical categories “Simultaneous Pancreas, Islet Cell and Kidney Transplant”, “Pancreas or Islet Cell Transplant” and “Simultaneous Pancreas, Islet Cell and Kidney Transplant with Hemodialysis”.

It was added in FY2025, effective October 1, 2024.

What each character means

1. Section
XNew Technology
2. Body System
WAnatomical Regions
3. Operation
0Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4. Body Part
3Peripheral Vein
5. Approach
3Percutaneous

Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure

6. Device / Substance / Technology
DDonislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension

Includes: Lantidra(tm)

7. Qualifier
ANew Technology Group 10

Other versions of this procedure

MS-DRG v44.0 grouping

All DRGs →

Surgical MS-DRGs this procedure can group to, depending on the principal diagnosis's MDC.

MDC PRE · Pre-MDC · Simultaneous Pancreas, Islet Cell and Kidney Transplant

MDC PRE · Pre-MDC · Pancreas or Islet Cell Transplant

MDC PRE · Pre-MDC · Simultaneous Pancreas, Islet Cell and Kidney Transplant with Hemodialysis

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2025 (effective 10/1/2024): Added
  • No changes since FY2025.

Common questions about XW033DA

Is XW033DA a valid ICD-10-PCS code for 2027?

Yes. XW033DA is valid for inpatient procedures from October 1, 2026 through September 30, 2027.

Is XW033DA an O.R. procedure?

No. XW033DA is designated non-O.R. in MS-DRG v44.0.

What DRG does XW033DA group to?

Depending on the principal diagnosis, XW033DA can group to MS-DRG 008, MS-DRG 010 and MS-DRG 019.